共 37 条
[1]
Groszmann R.J., Kravetz J., Bosch J., Et al., Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension, Hepatology, 2, pp. 757-762, (1982)
[2]
Mols P., Hallemans R., Kuyk M.V., Et al., Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension, Ann Surg, 199, pp. 176-181, (1984)
[3]
Tsai Y.T., Lay C.S., Lai K.H., Et al., Controlled trials of vasopressin plus nitroglycerin vs vasopressin alone in the treatment of bleeding esophageal varices, Hepatology, 6, pp. 406-409, (1986)
[4]
Gion A.E., Westaby D., Hegarty J., Et al., A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage, Hepatology, 6, pp. 410-413, (1986)
[5]
Westaby D., Gion A., Hayes P.C., Et al., Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension, Gut, 29, pp. 372-377, (1988)
[6]
Bosch J., Groszmann R.J., Garcia-Pagan J.C., Et al., Association of transdermal nitroglycerin and vasopressin infusion in the treatment of variceal hemorrhage: A placebo-controlled clinical trial, Hepatology, 10, pp. 962-968, (1989)
[7]
Bosch J., Kravetz D., Rodes J., Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin, Gastroenterology, 80, pp. 518-525, (1981)
[8]
Morgan J.S., Groszmann R.I., Somatostatin in portal hypertension, Digestive Diseases and Sciences, 34, pp. 40-47, (1989)
[9]
Wahren J., Eriksson L.S., The influence of a long-acting somatostatin analogue on splanchnic hemodynamics and metabolism in healthy subjects and patients with liver cirrhosis, Scand J Gastroenterol, 21, pp. 103-108, (1986)
[10]
Eriksson L.S., Brundin T., Soderlung C., Et al., Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis, Scand J Gastroenterol, 2, pp. 919-925, (1987)